WBP2 and non-small cell lung carcinoma: In this study, we attempted to verify WBP2 expression in clinical samples and cell lines, and then explored the underlying molecular mechanism involved in non-small cell lung cancer (NSCLC), providing an experimental basis for the identification of molecular markers of lung cancer and the development of targeted therapeutic agents.